ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Biosplice Therapeutics, Inc. clinical trials

Also known as Samumed.

The registry lists 22 studies whose lead sponsor is Biosplice Therapeutics, Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 21, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

What it is testing

The drugs Biosplice Therapeutics, Inc.’s studies test, most studies first; none is open now — 6 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

All 22 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed1568%
  • Stopped early732%Terminated 6 · Withdrawn 1

Phase

  • Phase 28
  • Phase 18
  • Phase 36

Where

  • United States20
  • Australia2
  • Turkey1
  • New Zealand1

Over the years

  1. 14
  2. 15
  3. 16
  4. 417
  5. 18
  6. 19
  7. 20
  8. 21
  9. 22
  10. 23
  11. 24
  12. 25
  13. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Biosplice Therapeutics, Inc.

  • Biosplice Therapeutics, Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    22 studies

Studies

Recruiting first, then most recently updated. Showing 22 of 22.